Prescription Medications Updated During February 2020, From Oldest to Newest, Page 50

Page 50 of 53 « First Page « … 5 10 15 20 25 … 48 49 50 51 52 … » Last Page »

DEXTROSE

Intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient…

HF Acquisition Co LLC, DBA HealthFirst27 February 2020

TachoSil (THROMBIN HUMAN and FIBRINOGEN)

TachoSil is a fibrin sealant patch indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery when control…

Baxter Healthcare Corporation27 February 2020

Nystatin

Nystatin cream is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. This cream is not indicated…

E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.27 February 2020

Sildenafil

Sildenafil for oral suspension is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in adults to improve exercise ability and delay clinical worsening. The…

Actavis Pharma, Inc.27 February 2020

Acetazolamide

For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma,…

Novitium Pharma LLC28 February 2020

Page 50 of 53 « First Page « … 5 10 15 20 25 … 48 49 50 51 52 … » Last Page »

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.